MedTrace Logo

Zainidip in Renal Artery Stenosis

NCT02594410 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2015-11-03

No results posted yet for this study

Summary

To evaluate the efficacy of renal artery stent combined with standardized medical therapy as treatment for renal artery stenosis.

Conditions

Interventions

DEVICE

stent

patients receiving renal artery stenting for renal artery atherosclerosis

DRUG

Aspirine

100mg Qd

DRUG

Clopidogrel

75mg Qd

DRUG

Lercanidipine

10-20mg Qd

Sponsors & Collaborators

  • Lee's Pharmaceutical Limited

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2014-03-31
Completion
2014-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02594410 on ClinicalTrials.gov